{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:46:13Z","timestamp":1782715573411,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The idea of \u201cstratified medicine\u201d is an important driver of methodological research on the identification of predictive biomarkers. Most methods proposed so far for this purpose have been developed for the use on randomized data only. However, often data from clinical registries or non-randomized studies are the only available data source. For such data, methods for estimation of the average treatment effect are well established. Research on confounder adjustment when investigating the heterogeneity of treatment effects and the variables responsible for this is usually restricted to regression modelling. In this paper, we demonstrate how the predMOB, a tree-based method that specifically searches for predictive factors, can be combined with common strategies for confounder adjustment. In an extensive simulation study, we show that the proposed strategies allow for the correct identification of predictive factors in the presence of confounding. It is demonstrated that the most robust method is a combination of both covariate adjustment and Inverse Probability of Treatment Weighting (IPTW). Applications to the German Breast Cancer Study Group (GBSG) trial 2 and the Acute Myeloid Leukemia Study Group (AMLSG) 16-10 study illustrate these conclusions.<\/jats:p>","DOI":"10.1186\/s12874-026-02928-8","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:15:44Z","timestamp":1782540944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tree-based exploratory identification of predictive biomarkers in non-randomized data"],"prefix":"10.1186","volume":"26","author":[{"given":"Julia","family":"Krzykalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Saadati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hielscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kopp-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Edelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"27","key":"2928_CR1","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1073\/pnas.1510489113","volume":"113","author":"S Athey","year":"2016","unstructured":"Athey S, Imbens G. Recursive partitioning for heterogeneous causal effects. Proc Natl Acad Sci U S A. 2016;113(27):7353\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2928_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"6","key":"2928_CR3","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1182\/bloodadvances.2022007223","volume":"18","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Weber D, et al. Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications. Blood Adv. 2022;18(6):5345\u201355.","journal-title":"Blood Adv"},{"issue":"12","key":"2928_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"issue":"7","key":"2928_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/aje\/kwv108","volume":"182","author":"JM Franklin","year":"2015","unstructured":"Franklin JM, Eddings W, Glynn RJ, Schneeweiss S. Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses. Am J Epidemiol. 2015;182(7):651\u20139.","journal-title":"Am J Epidemiol"},{"issue":"54","key":"2928_CR6","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.21105\/joss.02763","volume":"5","author":"K Goldfeld","year":"2020","unstructured":"Goldfeld K, Wujciak-Jens J. simstudy: Illuminating research methods through data generation. J Open Source Softw. 2020;5(54):2763.","journal-title":"J Open Source Softw"},{"issue":"5","key":"2928_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/aje\/kwm355","volume":"167","author":"S Greenland","year":"2008","unstructured":"Greenland S. Invited Commentary: Variable Selection versus Shrinkage in the Control of Multiple Confounders. Am J Epidemiol. 2008;167(5):523\u20139.","journal-title":"Am J Epidemiol"},{"key":"2928_CR8","doi-asserted-by":"publisher","unstructured":"Heinze G, Boulesteix AL, Kammer M, Morris TP, White IR, the Simulation Panel of\u00a0the STRATOS\u00a0initiative. Phases of methodological research in biostatistics\u2014Building the evidence base for new methods. Biom J. 2024;66(1):2200222. https:\/\/doi.org\/10.1002\/bimj.202200222.","DOI":"10.1002\/bimj.202200222"},{"key":"2928_CR9","doi-asserted-by":"publisher","unstructured":"Hothorn T. TH.data: TH\u2019s Data Archive. 2025. R package version 1.1-3. https:\/\/doi.org\/10.32614\/CRAN.package.TH.data. Accessed 30 Jan 2025.","DOI":"10.32614\/CRAN.package.TH.data"},{"key":"2928_CR10","first-page":"3905","volume":"16","author":"T Hothorn","year":"2015","unstructured":"Hothorn T, Zeileis A. partykit: A Modular Toolkit for Recursive Partytioning in R. J Mach Learn Res. 2015;16:3905\u20139.","journal-title":"J Mach Learn Res"},{"key":"2928_CR11","unstructured":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH Harmonised Tripartite Guideline: Ethnic factors in the acceptability of foreign clinical data E5 (R1). 1998. https:\/\/database.ich.org\/sites\/default\/files\/E5_R1_Guideline.pdf. Accessed 20 Nov 2025."},{"issue":"4","key":"2928_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40471-017-0131-y","volume":"4","author":"JW Jackson","year":"2017","unstructured":"Jackson JW, Schmid I, Stuart EA. Propensity scores in pharmacoepidemiology: beyond the horizon. Curr Epidemiol Rep. 2017;4(4):271\u201380.","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"2928_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/sim.8452","volume":"39","author":"J Krzykalla","year":"2020","unstructured":"Krzykalla J, Benner A, Kopp-Schneider A. Exploratory identification of predictive biomarkers in randomized trials with normal endpoints. Stat Med. 2020;39(7):923\u201339.","journal-title":"Stat Med"},{"issue":"1","key":"2928_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-5573-4-4","volume":"4","author":"SW Marshall","year":"2007","unstructured":"Marshall SW. Power for tests of interaction: effect of raising the Type I error rate. Epidemiol Perspect Innov. 2007;4(1):4.","journal-title":"Epidemiol Perspect Innov"},{"key":"2928_CR15","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna; 2025. https:\/\/www.R-project.org\/.\u00a0Accessed 30 Jan 2025."},{"issue":"3","key":"2928_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(SICI)1097-0258(19960215)15:3<263::AID-SIM165>3.0.CO;2-K","volume":"15","author":"C Schmoor","year":"1996","unstructured":"Schmoor C, Olschewski M, Schumacher M. Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med. 1996;15(3):263\u201371.","journal-title":"Stat Med"},{"issue":"3","key":"2928_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11634-018-0342-1","volume":"13","author":"H Seibold","year":"2019","unstructured":"Seibold H, Hothorn T, Zeileis A. Generalised linear model trees with global additive effects. Adv Data Anal Classif. 2019;13(3):703\u201325. https:\/\/doi.org\/10.1007\/s11634-018-0342-1.","journal-title":"Adv Data Anal Classif"},{"issue":"1","key":"2928_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/ijb-2015-0032","volume":"12","author":"H Seibold","year":"2016","unstructured":"Seibold H, Zeileis A, Hothorn T. Model-Based Recursive Partitioning for Subgroup Analyses. Int J Biostat. 2016;12(1):45\u201363.","journal-title":"Int J Biostat"},{"key":"2928_CR19","doi-asserted-by":"publisher","unstructured":"Seibold H, Zeileis A, Hothorn T. model4you: Stratified and Personalised Models Based on Model-Based Trees and Forests. 2024. R package version 0.9-8. https:\/\/doi.org\/10.32614\/CRAN.package.model4you. Accessed 30 Jan 2025.","DOI":"10.32614\/CRAN.package.model4you"},{"issue":"1","key":"2928_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-25","volume":"8","author":"C Strobl","year":"2007","unstructured":"Strobl C, Boulesteix AL, Zeileis A, Hothorn T. Bias in random forest variable importance measures: Illustrations, sources and a solution. BMC Bioinformatics. 2007;8(1):1\u201321.","journal-title":"BMC Bioinformatics"},{"key":"2928_CR21","first-page":"141","volume":"10","author":"X Su","year":"2009","unstructured":"Su X, Tsai CL, Wang H, Nickerson DM, Li B. Subgroup analysis via recursive partitioning. J Mach Learn Res. 2009;10:141\u201358.","journal-title":"J Mach Learn Res"},{"issue":"508","key":"2928_CR22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/01621459.2014.951443","volume":"109","author":"L Tian","year":"2014","unstructured":"Tian L, Alizadeh AA, Gentles AJ, Tibshirani R. A simple method for estimating interactions between a treatment and a large number of covariates. J Am Stat Assoc. 2014;109(508):1517\u201332.","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"2928_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/10629360600810434","volume":"76","author":"S Van Buuren","year":"2006","unstructured":"Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB. Fully conditional specification in multivariate imputation. J Stat Comput Simul. 2006;76(12):1049\u201364.","journal-title":"J Stat Comput Simul"},{"issue":"523","key":"2928_CR24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","volume":"113","author":"S Wager","year":"2018","unstructured":"Wager S, Athey S. Estimation and Inference of Heterogeneous Treatment Effects using Random Forests. J Am Stat Assoc. 2018;113(523):1228\u201342.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2928_CR25","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41598-021-82017-6","volume":"11","author":"M Wiesenfarth","year":"2021","unstructured":"Wiesenfarth M, Reinke A, Landman BA, Eisenmann M, Saiz LA, Cardoso MJ, et al. Methods and open-source toolkit for analyzing and visualizing challenge results. Sci Rep. 2021;11(1):2369.","journal-title":"Sci Rep"},{"key":"2928_CR26","unstructured":"W\u00f6rmann B. Fr\u00fche Nutzenbewertung neuer Arzneimittel in Deutschland. Subgruppen: Definition, Analyse und Kriterienkatalog. In: Gesundheitspolitische Schriftenreihe der DGHO, Band 8. Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie e.V. 2016."},{"issue":"4","key":"2928_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1467-9574.2007.00371.x","volume":"61","author":"A Zeileis","year":"2007","unstructured":"Zeileis A, Hornik K. Generalized M-fluctuation tests for parameter instability. Stat Neerl. 2007;61(4):488\u2013508.","journal-title":"Stat Neerl"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-026-02928-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:07:00Z","timestamp":1782713220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12874-026-02928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2928"],"URL":"https:\/\/doi.org\/10.1186\/s12874-026-02928-8","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The real-life data sets used in\n                      \n                      and\n                      \n                      \u00a0sections come from clinical trials which were approved by the respective ethics committees. Written informed consent was obtained from all trial participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable: The results presented in this manuscript are shown only in aggregated form, no individual person\u2019s data is presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}